Seroepidemiology of transfusion transmissible viral infection among university fresh students in Port Harcourt, Nigeria

Hepatitis Monthly

Volumn 9, Issue 4, 2009, Pages 276-281

  Jeremiah, Zaccheaus Awortu ^a   Tony Enwin, Evelyn Ovenome ^b  

^a NIGER DELTA UNIVERSITY   (Nigeria)

^b RIVERS STATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Nigeria)

Author keywords

HBsAg; HCV; HIV; Nigeria; Transfusion transmissible infection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD TRANSFUSION; COLLEGE STUDENT; DIAGNOSTIC KIT; ETHNIC GROUP; FEMALE; GENDER; GROUPS BY AGE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NIGERIA; POPULATION DISTRIBUTION; SEROEPIDEMIOLOGY; SEROPREVALENCE; VIRUS DETECTION; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 74049146753     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. UNAIDS Women and AIDS: UNAIDS point of view. UNAIDS. Geneva. 2007.
2. Tapko JB, Sam O, Diarra-Nama AJ. Status of blood safety in the WHO African region: report of the 2004 survey. World Health Organization. 2007.
3. Busch MP, Young MJ, Samson SM, Mosley JW, Ward JW, Perkins HA. Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group. Transfusion. 1991;31(1):4-11.
4. Everhart JE, Di Bisceglie AM, Murray LM, et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med. 1990;112(7):544-5.
5. HIV sero-prevalence sentinel report. Information for Policy Makers. Federal Ministry of Health. 2001:30-50.
6. Ejele OA, Erhabor O, Nwauche CA. The risk of transfusion-transmissible viral infections in the Niger-Delta area of Nigeria. Sahel Med J. 2005;8(1):16-9.
7. Erhabor O. The geometrically increasing prevalence of HIV infection and its attendant social implications in Port Harcourt Niger. Lab News J. 2001;4:27-9.
8. Szmuness W, Stevens CE, Ikram H, Much MI, Harley EJ, Hollinger B. Prevalence of hepatitis B virus infection and hepatocellular carcinoma in Chinese-Americans. J Infect Dis. 1978;137(6):822-9.
9. Baba MM, Gashau W, Hassan AW. Detection of hepatitis-B surface antigenaemia in patients mirth and without the manifestations of AIDS in Maiduguri, Nigeria. Nig Postgrad Med J. 1998;5:125-8.
10. Emmanuel JC, Bassett MT, Smith HJ, Paterson LE. Measurement of alanine aminotransferase (ALT) levels in Zimbabwean donor serum - a possible indicator of non-A, non-B hepatitis. Cent Afr J Med. 1989;35(8):469-70.
11. Alter MJ. Epidemiology of hepatitis C. Hepatology. 1997;26(3 Suppl 1):62S-5S.
12. Alter MJ, Gerety RJ, Smallwood LA, et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. J Infect Dis. 1982;145(6):886-93.
13. Barrera JM, Francis B, Ercilla G, et al. Improved detection of anti-HCV in post-transfusion hepatitis by a thirdgeneration ELISA. Vox Sang. 1995;68(1):15-8.
14. Ejele OA, Nwauche CA, Erhabor O. Seroprevalence of hepatitis C virus in the Niger Delta of Nigeria. Niger Postgrad Med J. 2006;13(2):103- 6.
15. Jeremiah ZA, Koate B, Buseri F, Emelike F. Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt blood donors and association with blood groups and other risk indicators. Blood Transfus. 2008;6(3):150-5.
16. Amadi AN, Mba IEK. Distribution of HIV Infections Among Blood Donors in Abia State. J Med Invest Pract. 2001;2:38-40.
17. Carswell JW. HIV infection in healthy persons in Uganda. AIDS. 1987;1(4):223-7.
18. Glynn SA, Kleinman SH, Schreiber GB, et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA. 2000;284(2):229-35.
19. Lesi OA, Kehinde MO. Hepatitis C virus infection in patients with sickle cell anaemia at the Lagos University Hospital. Niger Postgrad Med J. 2003;10(2):79-83.
20. Petrik J, Hewitt P, Barbara J, Allain J. Large-scale HCV RNA screening in first-time blood donors: the first step towards genomic screening of blood donations. HCV RNA Screening Study Group. Vox Sang. 1999;76(3): 159-62.
21. Akinsete AS, Akamu AS, Okany CC. Trends in HIV seropositivity among visa applicants in Lagos, Nigeria. A fiveyear survey 1992-1996. Niger Postgrad Med J. 1998;5:69-72.
22. Royce RA, Sena A, Cates W, Jr., Cohen MS. Sexual transmission of HIV. N Engl J Med. 1997;336(15):1072-8.
23. Gupta GR. How men's power over women fuels the HIV epidemic. BMJ. 2002;324(7331):183-4.
24. Baba MM, Hassan AW, Yakubu AM. The prevalence of hepatitis B surface antigen and human immunodeficiency virus in blood donors in Maiduguri Niger J Med. 1998;9:10-2.
25. Sirisena ND, Njoku MO, Idoko JA. Hepatitis B surface Antigenaemia in patients with Human Immunodeficiency Virus-1 (HIV-1) infection in Jos. Niger Med Pract. 2002;41:18-20.
26. Lodenyo H, Schoub B, Ally R, Kairu S, Segal I. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg. East Afr Med J. 2000;77(1):13-5.